ART-501 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

20,112 results for “ART-501”

Trials

View all 11611 →

Safety, Reactogenicity and Immunogenicity of HB-502 and HB-501 Versus Placebo in People With HIV on Suppressive ART

30 participants · First posted May 28, 2024

ARQ 501 in Subjects With Cancer

80 participants · First posted Jan 13, 2004

A Study Comparing the Pharmacokinetics (PK) of ABP 501 40 mg/0.4 mL (ABP 501-HCF) and ABP 501 40 mg/0.8 ml (ABP 501-LCF) in Healthy Adult Participants

372 participants · First posted Jun 18, 2023

Drugs

View all 4561 →

ART-101

ART-446

ART-237

Organizations

View all 138 →

ART Fertility Clinics LLC

United Arab Emirates

TOUCH ART - SAMEH FATHY

Egypt

University of Victoria

Canada

News

View all 3802 →

ART-501 Shows Promise in Phase 2a Trial for Autism Spectrum Disorder Treatment

FDA Extends Review of Neurotech's NT-501 for Macular Telangiectasia Type 2

Hummingbird Bioscience Doses First Patient in Phase I Trial of HER3-Targeted ADC HMBD-501

Page 1 of 2012